Recent Advances in Multiple Myeloma: Applying Real-world Evidence to Clinical Practice

被引：0
作者：
Fonseca, Rafael [1 ]
Costa, Luciano [2 ]
Nooka, Ajay K. [3 ]
Pianko, Matthew James [4 ]
机构：
[1] Mayo Clin, Phoenix, AZ 85054 USA
[2] ONeal Comprehens Canc Ctr, Birmingham, AL USA
[3] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[4] Univ Michigan Hlth, Ann Arbor, MI USA
来源：
ONCOLOGY-NEW YORK | 2022年 / 36卷 / 08期
关键词：
DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：506 / 510
页数：5
相关论文
共 50 条
  • [31] A real-world data analysis of predictors of early mortality after a diagnosis of multiple myeloma
    Grant, Shakira J.
    Wildes, Tanya M.
    Rosko, Ashley E.
    Silberstein, Juliet
    Giri, Smith
    CANCER, 2023, 129 (13) : 2023 - 2034
  • [32] Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis
    Dong, Sharlene
    Banerjee, Rahul
    Khan, Adeel M.
    Wang, Mengru
    Wang, Xiaoliang
    Afghahi, Anosheh
    Afrough, Aimaz
    Janakiram, Murali
    Wang, Bo
    Cowan, Andrew J.
    Sperling, Adam S.
    Anderson Jr, Larry D.
    Rajkumar, S. Vincent
    Kaur, Gurbakhash
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [33] Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents
    Gaultney, J. G.
    Franken, M. G.
    Tan, S. S.
    Redekop, W. K.
    Huijgens, P. C.
    Sonneveld, P.
    Uyl-de Groot, C. A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (01) : 41 - 47
  • [34] Real-world incidence and risk factors of bortezomib-related cardiovascular adverse events in patients with multiple myeloma
    Jang, Bitna
    Jeong, Jonghyun
    Heo, Kyu-Nam
    Koh, Youngil
    Lee, Ju-Yeun
    BLOOD RESEARCH, 2024, 59 (01)
  • [35] Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma
    Garcia-Guinon, Antoni
    Charry, Paola Andrea
    Jimenez, Maria
    Sarra, Josep
    Delgado, Izarbe
    de la Torre, Laura Segura
    Santaliestra, Marta
    Garcia-Pintos, Marta
    Gonzalez, Yolanda
    Senin, Alicia
    Motllo, Cristina
    Abella, Eugenia
    Cabezudo, Elena
    Granell, Miquel
    Sancho, Esther
    Herranz, Maria Jose
    Seres, Yasmina
    Gironella, Mercedes
    Soler, Juan Alfons
    Marti-Tutusaus, Josep Maria
    Ben Azaiz, Ran
    de Larrea, Carlos Fernandez
    ANNALS OF HEMATOLOGY, 2025, 104 (02) : 1177 - 1186
  • [36] Real-world treatment patterns, comorbidities, and disease-related complications in patients with multiple myeloma in the United States
    Song, Xue
    Cong, Ze
    Wilson, Kathleen
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (01) : 95 - 103
  • [37] "Real-world" data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group
    Katodritou, Eirini
    Vadikolia, Chrysanthi
    Lalagianni, Chrysavgi
    Kotsopoulou, Maria
    Papageorgiou, Georgia
    Kyrtsonis, Marie-Christine
    Matsouka, Panagiota
    Giannakoulas, Nikolaos
    Kyriakou, Despoina
    Karras, Georgios
    Anagnostopoulos, Nikolaos
    Michali, Evridiki
    Briasoulis, Evangelos
    Hatzimichael, Eleftheria
    Spanoudakis, Emmanouil
    Zikos, Panagiotis
    Tsakiridou, Anastasia
    Tsionos, Konstantinos
    Anargyrou, Konstantinos
    Symeonidis, Argiris
    Maniatis, Alice
    Terpos, Evangelos
    ANNALS OF HEMATOLOGY, 2014, 93 (01) : 129 - 139
  • [38] “Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group
    Eirini Katodritou
    Chrysanthi Vadikolia
    Chrysavgi Lalagianni
    Maria Kotsopoulou
    Georgia Papageorgiou
    Marie-Christine Kyrtsonis
    Panagiota Matsouka
    Nikolaos Giannakoulas
    Despoina Kyriakou
    Georgios Karras
    Nikolaos Anagnostopoulos
    Evridiki Michali
    Evangelos Briasoulis
    Eleftheria Hatzimichael
    Emmanouil Spanoudakis
    Panagiotis Zikos
    Anastasia Tsakiridou
    Konstantinos Tsionos
    Konstantinos Anargyrou
    Argiris Symeonidis
    Alice Maniatis
    Evangelos Terpos
    Annals of Hematology, 2014, 93 : 129 - 139
  • [39] Management of Relapsed and Refractory Multiple Myeloma: Recent advances
    Rathnam, Krishnakumar
    Saju, S. V. V.
    Honey, Susan Raju
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2022, 43 (06) : 458 - 472
  • [40] Carfilzomib and Pomalidomide: Recent Advances in the Treatment of Multiple Myeloma
    Highsmith, Kaitlin N.
    Chen, Sheree E.
    Horowitz, Sandy
    PHARMACOTHERAPY, 2014, 34 (09): : 927 - 940
12345